Ognian Neytchev

Ognian Neytchev

Auto-generated profile, based on publicly available information

Ognian Neytchev

Glasgow Geroscience Group School of Molecular Biosciences MVLS University of Glasgow Glasgow UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2021 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
TEThomas Ebert
Thomas Ebert
ONOgnian Neytchev
Ognian Neytchev
AWAnna Witasp
Anna Witasp
KKKarolina Kublickiene
Karolina Kublickiene
PSPeter Stenvinkel
Peter Stenvinkel
PSPaul G. Shiels
Paul G. Shiels
Significance: Chronic kidney disease (CKD) can be regarded as a burden of lifestyle disease that shares common underpinning features and risk factors with the aging process; it is a complex constituted by several adverse components, including chronic inflammation, oxidative stress, early vascular aging, and cellular senescence. Recent Advances: A systemic approach to tackle CKD, based on mitigating the associated inflammatory, cell stress, and damage processes, has the potential to attenuate the effects of CKD, but it also preempts the development and progression of associated morbidities. In effect, this will enhance health span and compress the period of morbidity. Pharmacological, nutritional, and potentially lifestyle-based interventions are promising therapeutic avenues to achieve such a goal. Critical Issues: In the present review, currents concepts of inflammation and oxidative damage as key patho-mechanisms in CKD are addressed. In particular, potential beneficial but also adverse effects of different systemic interventions in patients with CKD are discussed. Future Directions: Senotherapeutics, the nuclear factor erythroid 2-related factor 2–kelch-like ECH-associated protein 1 (NRF2-KEAP1) signaling pathway, the endocrine klotho axis, inhibitors of the sodium–glucose cotransporter 2 (SGLT2), and live bio-therapeutics have the potential to reduce the burden of CKD and improve quality of life, as well as morbidity and mortality, in this fragile high-risk patient group. Antioxid. Redox Signal. 35, 1426–1448.

Verified
Journal Article
Open access
PDF file
DMDonogh Maguire
Donogh Maguire
ONOgnian Neytchev
Ognian Neytchev
DTDinesh Talwar
Dinesh Talwar
DMDonald C McMillan
Donald C McMillan
PSPaul Shiels
Paul Shiels
Telomere biology, a key component of the hallmarks of ageing, offers insight into dysregulation of normative ageing processes that accompany age-related diseases such as cancer. Telomere homeostasis is tightly linked to cellular metabolism, and in particular with mitochondrial physiology, which is also diminished during cellular senescence and normative physiological ageing. Inherent in the biochemistry of these processes is the role of magnesium, one of the main cellular ions and an essential cofactor in all reactions that use ATP. Magnesium plays an important role in many of the processes involved in regulating telomere structure, integrity and function. This review explores the mechanisms that maintain telomere structure and function, their influence on circadian rhythms and their impact on health and age-related disease. The pervasive role of magnesium in telomere homeostasis is also highlighted.

21 December 2024 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
GPGiorgia Perri
Giorgia Perri
CFChloe French
Chloe French
CACésar Agostinis-Sobrinho
César Agostinis-Sobrinho
AAAtul Anand
Atul Anand
RARadiana Dhewayani Antarianto
Radiana Dhewayani Antarianto
OSOliver M Shannon
Oliver M Shannon
Biomarkers of aging serve as important outcome measures in longevity-promoting interventions. However, there is limited consensus on which specific biomarkers are most appropriate for human intervention studies. This work aimed to address this need by establishing an expert consensus on biomarkers of aging for use in intervention studies via the Delphi method. A 3-round Delphi study was conducted using an online platform. In Round 1, expert panel members provided suggestions for candidate biomarkers of aging. In Rounds 2 and 3, they voted on 500 initial statements (yes/no) relating to 20 biomarkers of aging. Panel members could abstain from voting on biomarkers outside their expertise. Consensus was reached when there was ≥70% agreement on a statement/biomarker. Of the 460 international panel members invited to participate, 116 completed Round 1, 87 completed Round 2, and 60 completed Round 3. Across the 3 rounds, 14 biomarkers met consensus that spanned physiological (eg, insulin-like growth factor 1, growth-differentiating factor-15), inflammatory (eg, high sensitivity C-reactive protein, interleukin-6), functional (eg, muscle mass, muscle strength, hand grip strength, Timed-Up-and-Go, gait speed, standing balance test, frailty index, cognitive health, blood pressure), and epigenetic (eg, DNA methylation/epigenetic clocks) domains. Expert consensus identified 14 potential biomarkers of aging which may be used as outcome measures in intervention studies. Future aging research should identify which combination of these biomarkers has the greatest utility.

18 August 2018 in Cells
Verified
Journal Article
Open access
PDF file
Nikolaos PanagiotouNikolaos Panagiotou
Nikolaos Panagiotou
ONOgnian Neytchev
Ognian Neytchev
CSColin Selman
Colin Selman
PSPaul Shiels
Paul Shiels
A more comprehensive understanding of the human ageing process is required to help mitigate the increasing burden of age-related morbidities in a rapidly growing global demographic of elderly individuals. One exciting novel strategy that has emerged to intervene involves the use of extracellular vesicles to engender tissue regeneration. Specifically, this employs their molecular payloads to confer changes in the epigenetic landscape of ageing cells and ameliorate the loss of functional capacity. Understanding the biology of extracellular vesicles and the specific roles they play during normative ageing will allow for the development of novel cell-free therapeutic interventions. Hence, the purpose of this review is to summarise the current understanding of the mechanisms that drive ageing, critically explore how extracellular vesicles affect ageing processes and discuss their therapeutic potential to mitigate the effects of age-associated morbidities and improve the human health span.

12 October 2023 in Journal of Internal Medicine
Verified
Journal Article
Open access
ONOgnian Neytchev
Ognian Neytchev
HEHelen Erlandsson
Helen Erlandsson
AWAnna Witasp
Anna Witasp
LNLouise Nordfors
Louise Nordfors
AQAbdul Rashid Qureshi
Abdul Rashid Qureshi
PSPaul Shiels
Paul Shiels
Background: Chronic kidney disease (CKD) is an age‐related disease that displays multiple features of accelerated ageing. It is currently unclear whether the two treatment options for end‐stage kidney disease (dialysis and kidney transplantation [KT]) ameliorate the accelerated uremic ageing process.Methods: Data on clinical variables and blood DNA methylation (DNAm) from CKD stage G3–G5 patients were used to estimate biological age based on blood biomarkers (phenotypic age [PA], n = 333), skin autofluorescence (SAF age, n = 199) and DNAm (Horvath, Hannum and PhenoAge clocks, n = 47). In the DNAm cohort, we also measured the change in biological age 1 year after the KT or initiation of dialysis. Healthy subjects recruited from the general population were included as controls.Results: All three DNAm clocks indicated an increased biological age in CKD G5. However, PA and SAF age tended to produce implausibly large estimates of biological age in CKD G5. By contrast, DNAm age was 4.9 years (p = 0.005) higher in the transplantation group and 5.9 years (p = 0.001) higher in the dialysis group compared to controls. This age acceleration was significantly reduced 1 year after KT, but not after 1 year of dialysis.Conclusions: Kidney failure patients displayed an increased biological age as estimated by DNAm clocks compared to population‐based controls. Our results suggest that KT, but not dialysis, partially reduces the age acceleration.

22 October 2025 in Journal of Internal Medicine
Verified
Journal Article
Open access
PSPaul Shiels
Paul Shiels
ONOgnian Neytchev
Ognian Neytchev
GBGillian Borland
Gillian Borland
PGPolina Germushkina
Polina Germushkina
Richard J JohnsonRichard J Johnson
Richard J Johnson
TWTina Woods
Tina Woods
Although research on ageing has largely concentrated on understanding the fundamental biology of the ageing process and devising pharmaceutical interventions in order to slow it down, increasing evidence has underscored the crucial role of environmental inputs across the life course and across generations, in shaping both individual and intergenerational trajectories of age‐related health. These include nutrition, air pollution, social deprivation, lifestyle factors, climate change and exposure to environmental toxins, including microplastics and nanoplastics. The development of the concept of the exposome of ageing and the emergence of the new field of ‘exposomics’ have identified a blind spot, in particular, for geroscience. The impact of the exposome affecting human ‘healthspan’ (i.e., years lived in good health), extending across generations, is significant and yet under‐explored in research. As such, it is under‐appreciated that the declining health of the planet will have intergenerational ripple effects, epigenetically priming adverse health in future generations. We discuss the capacity to manipulate our exposome to mitigate against such effects, by addressing root causes, rather than symptoms, of both physiological and planetary dysregulation, dysfunction and decay. We propose a systems‐based framework that reconnects research on ageing with exposomics and planetary ecology, creating a new field of ‘ecological or exposome pharmacology’, harnessing the activity of Nrf2 as a senotherapeutic intervention to improve trans‐ and intergenerational physiology in the face of declining planetary health.